Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty

Osteoarthritis (OA), a disease affecting different patient phenotypes, appears as an optimal candidate for personalized healthcare. The aim of the discussions of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group was to explore the value o...

Descripción completa

Detalles Bibliográficos
Autores principales: Arden, Nigel, Richette, Pascal, Cooper, Cyrus, Bruyère, Olivier, Abadie, Eric, Branco, Jaime, Brandi, Maria Luisa, Berenbaum, Francis, Clerc, Cécile, Dennison, Elaine, Devogelaer, Jean-Pierre, Hochberg, Marc, D’Hooghe, Pieter, Herrero-Beaumont, Gabriel, Kanis, John A., Laslop, Andrea, Leblanc, Véronique, Maggi, Stefania, Mautone, Giuseppe, Pelletier, Jean-Pierre, Petit-Dop, Florence, Reiter-Niesert, Susanne, Rizzoli, René, Rovati, Lucio, Tajana Messi, Eleonora, Tsouderos, Yannis, Martel-Pelletier, Johanne, Reginster, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516900/
https://www.ncbi.nlm.nih.gov/pubmed/26085027
http://dx.doi.org/10.1007/s40266-015-0276-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516900/
https://www.ncbi.nlm.nih.gov/pubmed/26085027
http://dx.doi.org/10.1007/s40266-015-0276-7

Ejemplares similares